-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Entrada Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
- Entrada Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 35.2 %.
- Entrada Therapeutics, Inc. annual Return On Equity for 2023 was -2.89 %, a 92.5% increase from 2022.
- Entrada Therapeutics, Inc. annual Return On Equity for 2022 was -38.7 %, a 77.8% increase from 2021.
- Entrada Therapeutics, Inc. annual Return On Equity for 2021 was -174 %, a 298% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)